Celldex Therapeutics, Inc. (NASDAQ:CLDX) Q2 2020 Earnings Conference Call - Final Transcript
Aug 06, 2020 • 04:30 pm ET
Welcome to the Celldex Therapeutics Midyear 2020 Conference Call. My name is James, and I'll be your operator for today's call. [Operator Instructions]
And then I'd like to turn the call over to Sarah Cavanaugh. Sarah, you may begin.
Thank you very much. Good afternoon and thank you all for joining us. With me on the call today are Anthony Marucci, Co-founder, President and CEO of Celldex; Dr. Tibor Keler, Co-founder, Executive Vice President and Chief Scientific Officer; Dr. Diane Young, Senior Vice President and Chief Medical Officer; Sam Martin, Senior Vice President and Chief Financial Officer; Dr. Margo Heath-Chiozzi, Senior Vice President of Regulatory; and Dr. Diego Alvarado, Senior Director of Research.
Before we begin our discussion, I would like to mention that today's speakers will be making forward-looking statements. Such statements reflect on current views with respect to future events and are based on assumptions and subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. Certain of the factors that might cause Celldex's actual results to differ materially from those in the forward-looking statements, include those set forth under the headings Risk Factors and Management's Discussion and Analysis of Financial Condition and Results of Operation in Celldex's annual report on Form 10-K, quarterly reports on Form 10-Q and its current reports on Form 8-K as well as those described in Celldex's other filings with the SEC and its press releases.
All forward-looking statements are expressly qualified in their entirety by this cautionary notice. You should carefully review all of these factors and be aware that there may be other factors that could cause these differences. These forward-looking statements are based on information, plans and estimates as of this call, and Celldex does not promise to update any forward-looking statements to reflect changes in underlying assumptions or factors, new information, future events or other changes.
Please be advised that the question-and-answer period will be held at the close of the call. I would also like to mention that because of the current COVID-19 situation and also two of our offices are located in the areas of the hurricane. We do have folks dialing in from a number of different remote locations. And I ask that you bear with us if phone lines are a little scratchy because we're dealing with multiple issues on that end.
So with that, I'd like to turn the call over to Anthony, Anthony?
Anthony S. Marucci
Thank you, Sarah. Good afternoon, everyone, and thank you for joining us. We hope you're all safe and healthy and appreciate you taking the time to connect with us today. We're looking forward to updating all of you on our progress and providing more detail on our plans for the future. I want to take a few minutes to review the recent events, and then I will ask Diane to update you on our clinical programs and Sam to review the financials.
We will close the call with your